A United Kingdom Register study of in-hospital outcomes of patients receiving extracorporeal carbon dioxide removal.

ABSTRACT:

Introduction

Extracorporeal membrane carbon dioxide removal may have a role in treatment of patients with hypercapnic respiratory failure and refractory hypoxaemia and/or hypercapnia.

Methods

We report on the use, outcomes and complications in United Kingdom intensive care units reporting patients on the Extracorporal Life Support Organisation register.

Results

Of 60 patients, 42 (70%) had primarily hypoxic respiratory failure and 18 (30%) primarily hypercapnic respiratory failure. Use of veno-venous procedures increased compared to arterio-venous procedures. Following extracorporeal membrane carbon dioxide removal, ventilatory and blood gas parameters improved at 24 h. Twenty-seven (45%) of patients died before ICU discharge, while 27 (45%) of patients were discharge

SUBMITTER: Cummins C 

PROVIDER: S-EPMC5956684 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature